다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
CERo Therapeutics Holdings Inc (CERO)
CERo Therapeutics Holdings Inc (CERO) 뉴스

CERO

CERo Therapeutics (CERO)

CERo Therapeutics Holdings Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CERO

1

일자	시간	출처	헤드라인	심볼	기업
2024/07/08	21:00	GlobeNewswire Inc.	CERo Therapeutics, Inc. Presents CER-1236 Data Supporting Use in AML at Global Cell & Gene Therapy Summit 2024	NASDAQ:CERO	CERo Therapeutics Holdings Inc
2024/06/13	21:15	GlobeNewswire Inc.	CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236	NASDAQ:CERO	CERo Therapeutics Holdings Inc
2024/06/06	21:00	GlobeNewswire Inc.	CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236	NASDAQ:CERO	CERo Therapeutics Holdings Inc
2024/05/15	21:00	GlobeNewswire Inc.	CERo Therapeutics, Inc. Provides Corporate Update for Shareholders	NASDAQ:CERO	CERo Therapeutics Holdings Inc
2024/04/30	22:00	GlobeNewswire Inc.	CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes	NASDAQ:CERO	CERo Therapeutics Holdings Inc
2024/03/07	21:00	Business Wire	CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients	NASDAQ:CERO	CERo Therapeutics Holdings Inc

검색 관련기사 보기:NASDAQ:CERO

1

Voya Prime Rate

iShares iBonds Dec 2025 ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관